| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,786 |
16,198 |
$1.85M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,604 |
2,377 |
$331K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,506 |
1,499 |
$167K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,594 |
1,559 |
$161K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,432 |
2,270 |
$132K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
5,338 |
5,186 |
$123K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
873 |
872 |
$98K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,514 |
5,861 |
$44K |
| 69210 |
|
756 |
676 |
$38K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,108 |
1,575 |
$33K |
| 87070 |
|
6,389 |
5,755 |
$33K |
| 86317 |
|
6,355 |
5,707 |
$32K |
| 87184 |
|
6,458 |
5,796 |
$27K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
195 |
193 |
$23K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,038 |
948 |
$12K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,278 |
3,125 |
$11K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
444 |
425 |
$11K |
| 99441 |
|
118 |
115 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
217 |
204 |
$5K |
| 99051 |
|
714 |
630 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
290 |
277 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
13 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
41 |
35 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
16 |
16 |
$2K |
| 99188 |
|
109 |
109 |
$1K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
101 |
78 |
$1K |
| 99050 |
|
87 |
86 |
$1K |
| 90461 |
|
803 |
790 |
$649.41 |
| 92567 |
|
39 |
39 |
$629.54 |
| 36415 |
Collection of venous blood by venipuncture |
1,651 |
1,587 |
$506.16 |
| 36410 |
|
27 |
26 |
$496.75 |
| 90686 |
|
297 |
296 |
$428.85 |
| 36400 |
|
15 |
15 |
$282.44 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
142 |
141 |
$44.34 |
| 81002 |
|
17 |
15 |
$27.04 |
| 96160 |
|
16 |
16 |
$19.80 |
| 94760 |
|
13 |
12 |
$15.60 |
| 99000 |
|
3,997 |
3,704 |
$14.09 |
| 36416 |
|
1,825 |
1,720 |
$10.56 |
| 90670 |
|
224 |
219 |
$0.00 |
| 90633 |
|
38 |
38 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
46 |
46 |
$0.00 |
| 90744 |
|
92 |
89 |
$0.00 |
| 90680 |
|
43 |
42 |
$0.00 |
| 90698 |
|
121 |
120 |
$0.00 |
| 90619 |
|
17 |
17 |
$0.00 |
| 90677 |
|
74 |
73 |
$0.00 |